453 related articles for article (PubMed ID: 31957152)
21. Efficacy of non-surgical treatments for androgenetic alopecia: a systematic review and network meta-analysis.
Gupta AK; Mays RR; Dotzert MS; Versteeg SG; Shear NH; Piguet V
J Eur Acad Dermatol Venereol; 2018 Dec; 32(12):2112-2125. PubMed ID: 29797431
[TBL] [Abstract][Full Text] [Related]
22. Observing the clinical efficacy of combined serum microneedle therapy for moderate to severe androgenetic alopecia in scalp repair.
Zhang F; Jia S; Ye B; Li F; Zhang J; Jin Q; Li M
Skin Res Technol; 2024 Feb; 30(2):e13612. PubMed ID: 38348763
[TBL] [Abstract][Full Text] [Related]
23. Controversies in the treatment of androgenetic alopecia: The history of finasteride.
Andy G; John M; Mirna S; Rachita D; Michael K; Maja K; Aseem S; Zeljana B
Dermatol Ther; 2019 Mar; 32(2):e12647. PubMed ID: 30253001
[TBL] [Abstract][Full Text] [Related]
24. Efficacy and safety of 3% minoxidil versus combined 3% minoxidil / 0.1% finasteride in male pattern hair loss: a randomized, double-blind, comparative study.
Tanglertsampan C
J Med Assoc Thai; 2012 Oct; 95(10):1312-6. PubMed ID: 23193746
[TBL] [Abstract][Full Text] [Related]
25. Androgenetic Alopecia: Therapy Update.
Devjani S; Ezemma O; Kelley KJ; Stratton E; Senna M
Drugs; 2023 Jun; 83(8):701-715. PubMed ID: 37166619
[TBL] [Abstract][Full Text] [Related]
26. A randomized, placebo-controlled trial of 1% topical minoxidil solution in the treatment of androgenetic alopecia in Japanese women.
Tsuboi R; Tanaka T; Nishikawa T; Ueki R; Yamada H; Katsuoka K; Ogawa H; Takeda K
Eur J Dermatol; 2007; 17(1):37-44. PubMed ID: 17324826
[TBL] [Abstract][Full Text] [Related]
27. Minoxidil: a comprehensive review.
Gupta AK; Talukder M; Venkataraman M; Bamimore MA
J Dermatolog Treat; 2022 Jun; 33(4):1896-1906. PubMed ID: 34159872
[TBL] [Abstract][Full Text] [Related]
28. Finasteride: a review of its use in male pattern hair loss.
McClellan KJ; Markham A
Drugs; 1999 Jan; 57(1):111-26. PubMed ID: 9951956
[TBL] [Abstract][Full Text] [Related]
29. A randomized, placebo-controlled trial of 5% and 2% topical minoxidil solutions in the treatment of female pattern hair loss.
Lucky AW; Piacquadio DJ; Ditre CM; Dunlap F; Kantor I; Pandya AG; Savin RC; Tharp MD
J Am Acad Dermatol; 2004 Apr; 50(4):541-53. PubMed ID: 15034503
[TBL] [Abstract][Full Text] [Related]
30. A novel topical combination of minoxidil and spironolactone for androgenetic alopecia: Clinical, histopathological, and physicochemical study.
Abdel-Raouf H; Aly UF; Medhat W; Ahmed SS; Abdel-Aziz RTA
Dermatol Ther; 2021 Jan; 34(1):e14678. PubMed ID: 33320406
[TBL] [Abstract][Full Text] [Related]
31. An Open-Label Randomized Multicenter Study Assessing the Noninferiority of a Caffeine-Based Topical Liquid 0.2% versus Minoxidil 5% Solution in Male Androgenetic Alopecia.
Dhurat R; Chitallia J; May TW; Jayaraaman AM; Madhukara J; Anandan S; Vaidya P; Klenk A
Skin Pharmacol Physiol; 2017; 30(6):298-305. PubMed ID: 29055953
[TBL] [Abstract][Full Text] [Related]
32. Combined treatment with oral finasteride and topical minoxidil in male androgenetic alopecia: a randomized and comparative study in Chinese patients.
Hu R; Xu F; Sheng Y; Qi S; Han Y; Miao Y; Rui W; Yang Q
Dermatol Ther; 2015; 28(5):303-8. PubMed ID: 26031764
[TBL] [Abstract][Full Text] [Related]
33. Androgenetic alopecia and current methods of treatment.
Bienová M; Kucerová R; Fiurásková M; Hajdúch M; Koláŕ Z
Acta Dermatovenerol Alp Pannonica Adriat; 2005 Mar; 14(1):5-8. PubMed ID: 15818439
[TBL] [Abstract][Full Text] [Related]
34. Intradermal injections with 0.5% minoxidil for the treatment of female androgenetic alopecia: A randomized, placebo-controlled trial.
Uzel BPC; Takano GHS; Chartuni JCN; Cesetti MV; Gavioli CFB; Lemes AM; Costa IMC
Dermatol Ther; 2021 Jan; 34(1):e14622. PubMed ID: 33269529
[TBL] [Abstract][Full Text] [Related]
35. Clinical Efficacy of a Topical Compounded Formulation in Male Androgenetic Alopecia: Minoxidil 10%, Finasteride 0.1%, Biotin 0.2%, and Caffeine Citrate 0.05% Hydroalcoholic Solution.
Marotta JC; Patel G; Carvalho M; Blakeney S
Int J Pharm Compd; 2020; 24(1):69-76. PubMed ID: 32023218
[TBL] [Abstract][Full Text] [Related]
36. Finasteride increases anagen hair in men with androgenetic alopecia.
Van Neste D; Fuh V; Sanchez-Pedreno P; Lopez-Bran E; Wolff H; Whiting D; Roberts J; Kopera D; Stene JJ; Calvieri S; Tosti A; Prens E; Guarrera M; Kanojia P; He W; Kaufman KD
Br J Dermatol; 2000 Oct; 143(4):804-10. PubMed ID: 11069460
[TBL] [Abstract][Full Text] [Related]
37. Pediatric androgenetic alopecia: an updated review.
Gomes TF; Soares RO
J Dtsch Dermatol Ges; 2023 Jan; 21(1):19-25. PubMed ID: 36688435
[TBL] [Abstract][Full Text] [Related]
38. A randomized clinical trial of 5% topical minoxidil versus 2% topical minoxidil and placebo in the treatment of androgenetic alopecia in men.
Olsen EA; Dunlap FE; Funicella T; Koperski JA; Swinehart JM; Tschen EH; Trancik RJ
J Am Acad Dermatol; 2002 Sep; 47(3):377-85. PubMed ID: 12196747
[TBL] [Abstract][Full Text] [Related]
39. The use of minoxidil in the treatment of male and female androgenetic alopecia: a story of more than 30 years.
Barbareschi M
G Ital Dermatol Venereol; 2018 Feb; 153(1):102-106. PubMed ID: 29319278
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
